查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1790346

美国细胞培养基和细胞株市场规模、份额和趋势分析报告：按产品、应用、最终用途和细分市场预测，2025 年至 2033 年

U.S. Cell Culture Media & Cell Lines Market Size, Share & Trends Analysis Report By Product (Traditional Cell Line, Classical Media), By Application (Biopharmaceutical Production, Diagnostics), By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

市场规模和趋势

美国细胞培养基和细胞株市场规模预计将在 2024 年达到 19.7 亿美元，到 2033 年将达到 43.6 亿美元，2025 年至 2033 年的复合年增长率为 9.45%。

这一增长将受到生物製药製造需求的不断增长、再生医学的进步以及研发活动投资的不断增加的推动。此外，细胞培养技术在药物发现和个人化医疗中的日益广泛的应用预计将在预测期内推动市场扩张。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国细胞培养基和细胞株市场变数和趋势

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国细胞培养基与细胞株市场分析工具
    • 产业分析—波特五力分析
    • PESTEL分析

第四章：美国细胞培养基与细胞株市场（依产品、估价及趋势分析）

  • 产品细分仪表板
  • 美国细胞培养基与细胞株市场产品波动分析
  • 2021-2033 年美国细胞培养基及细胞株市场规模及趋势分析（依产品）
  • 常规细胞株
    • 市场规模与趋势分析（按产品，2021-2033）
  • 常规培养基
    • 市场规模与趋势分析（按产品，2021-2033）
  • 干细胞和血液衍生细胞
    • 市场规模与趋势分析（按产品，2021-2033）
  • 专用培养基产品
    • 市场规模与趋势分析（按产品，2021-2033）

第五章：美国细胞培养基和细胞株市场的应用、预测与趋势分析

  • 应用程式细分仪表板
  • 美国细胞培养基和细胞株市场使用变化分析
  • 美国细胞培养基及细胞株市场规模及应用趋势分析（2021-2033）
  • 生物製药製造
  • 诊断
  • 药物筛检与开发
  • 组织工程与再生医学
  • 其他的

第六章：美国细胞培养基和细胞株市场（依最终用途、估计和趋势分析）

  • 最终用途细分仪表板
  • 美国细胞培养基和细胞株市场的最终用途差异分析
  • 美国细胞培养基及细胞株市场规模及趋势分析（依最终用途）（2021-2033）
  • 大型生物製药公司
  • 中小型生技公司
  • 合约研究与製造组织（CRO/CMO）
  • 研究和学术机构
  • 医院和诊断实验室
  • 其他的

第七章 竞争态势

  • 公司/竞争对手分类
  • 战略地图
  • 2024年企业市场分析
  • 公司简介/上市公司
    • Sartorius AG
    • Danaher
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • FUJIFILM Corporation
    • Lonza
    • STEMCELL Technologies
    • PromoCell GmbH
    • ATCC
    • AllCells
Product Code: GVR-4-68040-680-4

Market Size & Trends:

The U.S. cell culture media & cell lines market size was valued at USD 1.97 billion in 2024 and is anticipated to reach USD 4.36 billion by 2033, growing at a CAGR of 9.45% from 2025 to 2033. This growth is driven by increasing demand for biopharmaceutical production, advancements in regenerative medicine, and rising investments in research and development activities. Moreover, the expanding application of cell culture technologies in drug discovery and personalized medicine will fuel market expansion further over the forecast period.

U.S. Cell Culture Media And Cell Lines Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For

this study, Grand View Research has segmented the U.S. cell culture media & cell lines market report on the basis of product, application, and end use.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Traditional Cell Lines
  • Classical Media
  • Stem Cells & Blood-derived Cells
  • Specialty Media Products
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Biopharmaceutical Production
  • Diagnostics
  • Drug Screening and Development
  • Tissue Engineering and Regenerative Medicine
  • Other Applications
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Large Biopharmaceutical Companies
  • Small and Mid-sized Biotechnology Companies
  • Contract Research and Manufacturing Organizations (CROs/CMOs)
  • Research and Academic Institutes
  • Hospitals and Diagnostic Laboratories
  • Other End Uses

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product Segment
    • 1.2.2. Application Segment
    • 1.2.3. End Use Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Cell Culture Media & Cell Lines Market Variables & Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Advancements in Regenerative Medicine
      • 3.2.1.2. Advancements in Technology and Data Analytics
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Cost of Specialized Media and Cell Lines
      • 3.2.2.2. Stringent Regulatory and Quality Requirements
  • 3.3. U.S. Cell Culture Media & Cell Lines Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. U.S. Cell Culture Media & Cell Lines Market: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. U.S. Cell Culture Media & Cell Lines Market Product Movement Analysis
  • 4.3. U.S. Cell Culture Media & Cell Lines Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Traditional Cell Lines
    • 4.4.1. Traditional Cell Lines Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.5. Classical Media
    • 4.5.1. Classical Media Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.6. Stem Cells & Blood-derived Cells
    • 4.6.1. Stem Cells & Blood-derived Cells Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.7. Specialty Media Products
    • 4.7.1. Specialty Media Products Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)

Chapter 5. U.S. Cell Culture Media & Cell Lines Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. U.S. Cell Culture Media & Cell Lines Market Application Movement Analysis
  • 5.3. U.S. Cell Culture Media & Cell Lines Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Biopharmaceutical Production
    • 5.4.1. Biopharmaceutical Production market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Diagnostics
    • 5.5.1. Diagnostics market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Drug Screening and Development
    • 5.6.1. Drug Screening and Development market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Tissue Engineering and Regenerative Medicine
    • 5.7.1. Tissue Engineering and Regenerative Medicine market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.8. Other Applications
    • 5.8.1. Other Applications market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Cell Culture Media & Cell Lines Market: End use Estimates & Trend Analysis

  • 6.1. End use Segment Dashboard
  • 6.2. U.S. Cell Culture Media & Cell Lines Market End use Movement Analysis
  • 6.3. U.S. Cell Culture Media & Cell Lines Market Size & Trend Analysis, by End use, 2021 to 2033 (USD Million)
  • 6.4. Large Biopharmaceutical Companies
    • 6.4.1. Large Biopharmaceutical Companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Small and Mid-sized Biotechnology Companies
    • 6.5.1. Small and Mid-sized Biotechnology Companies market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Contract Research and Manufacturing Organizations (CROs/CMOs)
    • 6.6.1. Contract Research and Manufacturing Organizations (CROs/CMOs) market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Research and Academic Institutes
    • 6.7.1. Research and Academic Institutes market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8. Hospitals and Diagnostic Laboratories
    • 6.8.1. Hospitals and Diagnostic Laboratories market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9. Other End Uses
    • 6.9.1. Other End Uses market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Sartorius AG
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Danaher
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Merck KGaA
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Thermo Fisher Scientific, Inc.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. FUJIFILM Corporation
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Lonza
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. STEMCELL Technologies
      • 7.4.7.1. Company overview
      • 7.4.7.2. Product benchmarking
      • 7.4.7.3. Strategic initiatives
    • 7.4.8. PromoCell GmbH
      • 7.4.8.1. Company overview
      • 7.4.8.2. Product benchmarking
      • 7.4.8.3. Strategic initiatives
    • 7.4.9. ATCC
      • 7.4.9.1. Company overview
      • 7.4.9.2. Product benchmarking
      • 7.4.9.3. Strategic initiatives
    • 7.4.10. AllCells.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Product benchmarking
      • 7.4.10.3. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 U.S. cell culture media & cell lines Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 U.S. cell culture media & cell lines Market, By Application, 2021 - 2033 (USD Million)
  • Table 6 U.S. cell culture media & cell lines Market, By End use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 U.S. cell culture media & cell lines market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Data analysis models
  • Fig. 4 Market formulation and validation
  • Fig. 5 Data validating & publishing
  • Fig. 6 Market research process
  • Fig. 7 Information procurement
  • Fig. 8 Primary research
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 U.S. cell culture media & cell lines market: Product outlook key takeaways
  • Fig. 13 U.S. cell culture media & cell lines market: Product movement analysis
  • Fig. 14 U.S. traditional cell lines market, 2021 - 2033 (USD Million)
  • Fig. 15 U.S. traditional cell lines market, 2021 - 2033 (USD Million)
  • Fig. 16 U.S. classical media market, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. stem cells & blood-derived cells U.S. cell culture media & cell lines market, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. specialty media products U.S. cell culture media & cell lines market, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. cell culture media & cell lines market: Application outlook and key takeaways
  • Fig. 20 U.S. cell culture media & cell lines market: Application movement analysis
  • Fig. 21 U.S. biopharmaceutical production market, 2021 - 2033 (USD Million)
  • Fig. 22 U.S. diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. drug screening and development market, 2021 - 2033 (USD Million)
  • Fig. 24 U.S. tissue engineering and regenerative medicine market, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. other market, 2021 - 2033 (USD Million)
  • Fig. 26 U.S. cell culture media & cell lines market: End use outlook and key takeaways
  • Fig. 27 U.S. cell culture media & cell lines market: End use movement analysis
  • Fig. 28 U.S. large biopharmaceutical companies market, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. small and mid-sized biotechnology companies market, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. contract research and manufacturing organizations (CROs/CMOs) market, 2021 - 2033 (USD Million)
  • Fig. 31 U.S. research and academic institutes market, 2021 - 2033 (USD Million)
  • Fig. 32 U.S. hospital and diagnostic laboratories market, 2021 - 2033 (USD Million)
  • Fig. 33 U.S. other end use market, 2021 - 2033 (USD Million)